Combination Probiotic Trial
Phase 1/2
70
about 9.6 years
4–16
1 site in TX
What this study is about
This trial is testing a combination probiotic (BB-12 with LGG) at different doses in children with autism spectrum disorder and gastrointestinal symptoms. The goal is to see if the probiotic is safe and well-tolerated, as well as how it affects behaviors, GI symptoms, and biomarkers related to inflammation, gut bacteria, and metabolites.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take BB-12 with LGG (Higher Dose)
- 2.Take BB-12 with LGG (Lower Dose)
- 3.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Effects of BB-12+LGG at different doses on adverse events (safety)
Psychiatry / Mental Health